SERENDEM study: high dose biotin in patients suffering from disability related to peripheral nerve diseases SERENDEM study: high dose biotin in patients suffering from disability related to peripheral nerve d ...
SERENDEM study: MD1003 in patients suffering from demyelinating neuropathies, an open label pilot study SERENDEM study: MD1003 in patients suffering from demyelinating neuropathies, an open label pilot st ...
chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating neuropathy associated with immunoglobulin M (IgM) monoclonal gammopathy and antibodies against myelin-associated glycoprotein (MAG), Charcot Marie Tooth Ia (CMT Ia) neuropathy MedDRA version: 18.1;Level: LLT;Classification code 10066137;Term: Anti-MAG neuropathy;System Organ Class: 10029205 - Nervous system disorders MedDRA version: 18.1;Level: PT;Classification code 10057645;Term: Chronic inflammatory demyelinating polyradiculoneuropathy;Classification code 10008414;Term: Charcot-Marie-Tooth disease;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating neuropathy associated with ...